Ubs Asset Management Americas Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,290,154 shares of ARWR stock, worth $45.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,290,154
Previous 933,900
145.22%
Holding current value
$45.8 Million
Previous $26.7 Million
122.85%
% of portfolio
0.02%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding ARWR
# of Institutions
293Shares Held
91.7MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$313 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$244 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$178 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$117 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$82.7 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.11B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...